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Biomarker AUC P-value vs. aggregate
Cartilage thickness 0.60 0.008
Cartilage smoothness 0.79 0.33
Cartilage homogeneity 0.67 0.041
Cartilage volume 0.58 0.011
Cartilage curvature 0.76 0.24
uCTX-II 0.71 <0.001
Bone structure 0.77 0.075
Aggregate: All biomarkers 0.85 –
Conclusions: The complexity and heterogeneity of OA makes it unlikely
that a single marker will allow a comprehensive quantiﬁcation. Therefore,
aggregate markers based on measurements from different modalities and
targeting different anatomical structures could potentially be superior.
The results showed that the very different OA biomarkers each provided
some diagnostic ability. However, the aggregate combination marker was
superior and demonstrated the potential for multi-model markers. The
potential challenge of quantifying many markers was overcome by mainly
using fully automatic computer-based MRI markers allowing scalability to
large, multi-center studies.
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Purpose: Pain is the most prominent and disabling symptom of osteoarthri-
tis (OA). Despite its importance, much remains unknown about OA pain.
Current assessment methods for pain are subjectively evaluated by the
patients.
The gold standard for assessing joint damage is still the radiograph.
However, this method only provides a historical view of the damage, and
is rather insensitive and does not allow for the early detection of joint
damage. In addition, there are weak associations between pain severity and
radiographic change.
There is an urgent need for reliable, quantitative, and dynamic tests that
will detect early joint damage. Biomarkers, in addition to MRI, are expected
to be candidates that can detect the cartilage, bone and synovium turnover
for an objective and eﬃcient assessment of the joint damage in OA.
The present study sought to detect early-stage knee OA based on criteria
involving the presence of pain using the biomarkers.
Methods: The 46 subjects were enrolled in this study. Following the
traditional deﬁnition for OA, the subjects with the K/L 1 were diagnosed
as having an absence of OA and those with KL2 were diagnosed as having
knee OA. Pain in the knee was assessed using a visual analogue scale (VAS).
The biomarkers used were for serum collagen type II cleavage (sC2C),
synthesis of type II collagen carboxy propeptide (sCP II), hyaluronic acid
(sHA), urinary type II collagen C-telopeptide (uCTX-II/Cr), and N-terminal
crosslinking telopeptide of type I collagen (uNTx/Cr). The serum and urinary
levels of these biomarkers were applied to logarithmic transformation, and
they were adjusted for age, sex and body mass index for comparison. The
parametric comparisons used analysis of variance (ANOVA). A p<0.05 was
considered to be signiﬁcant.
Results: The 46 subjects consisted of 30 subjects with K/L 1 and 16 with
K/L 2. 16 subjects had knee pain, and remaining 30 subjects did not have
knee pain. The 30 subjects without knee pain consisted of 22 subjects with
K/L 1 and the 8 subjects with K/L 2. 8 subjects with knee pain showed
radiographic K/L 1 and, the remaining 8 showed K/L 2.
First, the subjects were divided into two groups according to the presence
or absence of a radiographic OA. No signiﬁcant differences of the sC2C,
uCTX-II/Cr and uNTx/Cr were observed between the subjects with K/L1
and those with K/L2. The sCPII in the subjects with K/L2 were signiﬁcantly
reduced in comparison to those with K/L2, while the sHA showed opposite.
Second, the subjects were divided into two groups according to the pres-
ence or absence of a knee pain. The sC2C, uCTX-II/Cr, sCPII and sHA were
signiﬁcantly increased in those with knee pain in comparison to those
without knee pain. No signiﬁcant differences of the uNTx/Cr were observed
between these two groups.
Third, the subjects were divided into four groups according to the presence
or absence of both radiographic knee OA and knee pain. The sC2C in the
subjects with K/L 1 and knee pain signiﬁcantly increased in comparison
to the subjects with K/L 1 and 2 without knee pain. The sCPII in the
subjects with K/L 1 and knee pain increased in comparison to those in
other three groups. The uCTX-II/Cr in the subjects with K/L 2 and knee pain
signiﬁcantly increased in comparison to those in the subjects with K/L 1
and 2 without knee pain. No signiﬁcant differences of the uNTx/Cr were
observed between these four groups. The sHA in the subjects with K/L 2
with and without knee pain signiﬁcantly increased in comparison to those
in the subjects with K/L 1 without knee pain.
Conclusions These results suggest that osteoarthritic knee pain in early-
stage knee OA, such as not only K/L 2 but also K/L 1, is associated with
metabolic changes revealed by these biomarkers, namely anabolic, catabolic
and inﬂammatory responses involving cartilage and probably synovium,
while it is not associated with gross radiographic changes of the knee and
how these changes trigger pain still remains unclear.
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Introduction: Standard morphometric cartilage parameters of volume and
average cartilage thickness have shown very low responsiveness to OA
progression, which limits their utility for OA clinical trials. However, a
novel automated atlas based standardized measurement method allows the
use of advance image analysis methodologies to quantify point by point
changes in cartilage thickness. The data from this point by point atlas based
process provides a more sensitive analysis of OA progression.
Objective: To evaluate the sensitivity of an atlas based standardized
measurement method to detect changes in articular cartilage thickness in
subjects with OA symptoms but no radiological evidence of OA.
Methods: The baseline, 12 month and 24 month DESS sagittal MRI knee
images of 133 subjects from the OAI progression cohort releases: 0.C.2,
1.C2, 3.C.1 were segmented to bones and articular cartilage using a fully
automated atlas based segmentation algorithm and a previously developed
anatomic atlas. All segmentations were evaluated for quality; 4 subjects
were removed due to large segmentation errors. Using the atlas deforma-
tions 3D map, all the cartilage thickness maps were mapped back to the
anatomic atlas, and were compared point by point to the atlas cartilage
thicknesses. After the thickness measurements were mapped onto the
atlas space, all cartilage measurements were compared to the baseline
measurement by a point by point subtraction. The change in thickness
values from baseline were statistically described by mean, variance and
percentiles of thickness change values for each subject and for each
cartilage plate. The quantiﬁcation was done on cMF, cLF, MT, LT, F, T,
medial WB, lateral WB and the entire tibia femoral joint (TF). The paired
KL scores of the 133 subjects and the JSN OARSI scores provided by the
OAI site (http://www.oai.ucsf.edu) were used to identify the subjects with
Table 1. The annualized change, the standard deviation of the residuals, the annualized
standard response of the mean (SRM) and the proportion of subjects that change mea-
surement from the 12 month to the 24 month visit are shown for the average cartilage
change, the standard difference of changes, and the average values of the lower 5% per-
centile of changes are shown for the different cartilage regions
*Statistically signiﬁcant form zero (p<0.05). ** are proportions statistically different from
0.5 (p<0.05)
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no radiological evidence of OA (KL<2). The longitudinal data was analyzed
using generalized least squares adjusted to JSN score and height with a
covariance structure grouped by subject and using time as continuous
covariate.
Results: From the 133 analyzed subjects, 18 subjects met the analysis
criteria (KL<2). Table 1 shows the results of the quantitative analysis of
change.
Conclusions: Our results show that a signiﬁcant proportion (74% to 83%)
of subjects with frequent knee pain and stiffness and KL scores lower than
2 had statistically signiﬁcant changes in articular cartilage thickness at
the WB regions. Based on these results subjects with OA symptoms but
no radiographic evidence of OA may be staged and monitored for disease
progression. The SRM of the mean on the order of 0.8 allows the design of
clinical trials of reasonable size for this kind of population.
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Purpose: To explore in a Phase III clinical trial in knee osteoarthritis (OA)
patients, the impact of disease-modifying OA drug (DMOAD) treatment on
biomarker levels.
Methods: 161 knee OA patients (according-to-protocol population) were
selected from a two-year DMOAD trial studying the effect of licofelone
(200 mg bid) versus naproxen (500 mg bid). MRI was done at baseline
and two years. Patients underwent clinical evaluation using the WOMAC
questionnaire. Seven OA biomarkers were measured at baseline and two
years: MMP-1, MMP-3, IL-6, CRP, COMP, and CTX-I in serum, and CTX-II in
urine.
Results: Over time an increase in all biomarker levels was found with
the exception of IL-6, CRP, and CTX-II, which decreased. The increase
in MMP-1 and MMP-3 was signiﬁcantly less (p<0.05; p<0.0001) in the
licofelone than the naproxen group. The MMP-1 level at baseline was a
signiﬁcant predictor (inverse correlation) of cartilage volume change for the
medial compartment (univariate, p=0.043; multivariate regression analysis,
p=0.038) and COMP, a positive predictor for the lateral compartment
(univariate p<0.0001; multivariate p<0.002). IL-6 and CRP also presented
a signiﬁcant relation to the volume change for the medial compartment
but only in the univariate model (p=0.038 and p=0.007, respectively). A
signiﬁcant association was observed in the univariate model between the
change in the level of MMP-1 (p=0.034), MMP-3 (p=0.019), and cartilage
loss (lateral compartment) over two years. Baseline levels of CTX-I cor-
related (p=0.02) with increase in bone marrow lesion size in the medial
compartment. The CRP levels at baseline correlated positively with wors-
ening of symptoms: WOMAC total index (p=0.0009), pain (p=0.002) and
function (p=0.001).
Conclusions: This study demonstrated that higher baseline values of IL-6,
CRP, and COMP were predictive of a greater risk of OA cartilage loss. How-
ever, over time a reduction in the MMP-1 and MMP-3 levels correlated best
with a reduction in the loss of cartilage and the effect of drug treatment.
The baseline CRP was found to be a good predictor of the symptomatic
response to treatment.
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Purpose: Recent evidences led to the conclussion that mitochondria me-
diate in the pathogenesis of the osteoarthritis (OA). Biomarkers are a
promising tool to detect patients with OA preferably in an early stage of the
disease. In this work we aim to assess a mitochondria-related phenotype in
patients with OA.
Methods: We analyzed the results from our previous determinations of
serum levels of several OA-related biomarkers such as MMP-1, MMP-3,
MMP-13, MPO, Coll2-1 Coll2-1NO2, C2C, CPII, hyaluronic acid, YKL-40,
COMP and cathepsin K, in 48 OA patients and 52 healthy controls carrying
the haplogroups H and J, to perform logistic regression models and receiver
operating characteristic (ROC) curves that permit us to predict diagnosis
of OA. This models also included clinical variables such as gender, age and
smoking status.
Results: The MMP-13 was the only biomarker signiﬁcantly increased in
OA patients, when compared with healthy controls, in both mtDNA hap-
logroups H and J (p<0.001). Type II collagen biomarkers such as Coll2-1,
Coll2-1NO2, Coll2 ratio, C2C, CPII and C2C:CPII ratio were signiﬁcantly
increased in OA patients that carry the mtDNA haplogroup H when com-
pared with OA carriers of the mtDNA haplogroup J (p<0.01 in all cases).
Two logistic regression models for diagnosis, adjusted for age, gender and
smoking status, were constructed. For haplogroup H, the regression model
obtained showed that the biomarkers signiﬁcantly associated with OA were
hyaluronic acid and C2C:CPII; the area under the curve (AUC) of the ROC
curve for this model was 0.926 (95% CI=0.857-0.995) and the optimal prob-
ability cutoff for discriminate between OA and healthy controls was 0.269,
with a sensitivity of 96%, a speciﬁcity of 78%, and a positive likelihood
ratio of 4.3. For haplogroup J, the biomarkers signiﬁcantly associated with
OA were MMP-13, MMP-3 and C2C; the AUC for this model was 0.880
(95% CI=0.782-0.978), and the optimal probability cutoff for discriminate
between OA patients and healthy controls was 0.271, with a sensitivity of
96%, a speciﬁcity of 68%, and a positive likelihood ratio of 3.
Conclusions: The MMP-13 appears to be a good candidate diagnosis
biomarker for OA. Some of the OA-related biomarkers clearly show a
different proﬁle depending on the mtDNA haplogroup. This permitted us to
perform two models of diagnosis of OA haplogroup-based.
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Purpose: Obesity is a major risk factor of osteoarthritis. The link between
obesity and osteoarthritis (OA) may be explained by the increased joint
stress accompanying obesity. However, it does not explain why being
obese is also associated with osteoarthritis in non-weight-bearing joints,
such as the hands. It is suggested that systemic products of fat with
systemic metabolic activity may inﬂuence the onset and/or progression of
osteoarthritis. We investigated here the association between three most
common adipokines: leptin, adiponectin and resistin and the progression
of hand osteoarthritis.
Methods: We selected patients with radiographic hand OA (HOA) from the
GARP (Genetic ARthrosis and Progression) cohort. In this cohort, Caucasian
sibs with predominantly symptomatic OA at multiple sites were included.
We deﬁned HOA as Kellgren and Lawrence score ≥2 in at least two
from 20 hand joints (four proximal interphalangeal joints (PIP’s), four
distal interphalangeal joints (DIP’s), one interphalangeal (IP-1) and one
carpometacarpal (CMC-1) on each hand). Using the Osteoarthritis Research
Society International atlas, the baseline and 6-years follow-up radiograph
were assessed for the joint space narrowing (JSN, grade 0 to 3: 0 normal,
3: severe narrowing) of 20 joints (four DIP’s, four PIP’s, one IP-1 and one
CMC-1) per patient. JSN reﬂects articular cartilage damage. The radiographs
were assessed by two readers in consensus and the intra-class correlation
coeﬃcient for intra-reader reproducibility based on 25 randomly selected
pairs of radiographs was high (0.87). Progression was deﬁned as a change
in JSN above the smallest detectable change (SDC) of 2, reﬂecting change
above measurement error. Baseline serum adiponectin concentration was
measured by Bio-Plex Pro Assay (Bio-Rad, USA). With logistic regression
analysis odds ratios of hand osteoarthritis progression were computed and
transformed to risk ratio (RRs). Adjustments for confounders as age, sex,
body mass index (BMI) and family effect were made. We categorized all
adipokines in tertiles.
Results: Of 248 included patietns, complete follow-up data were available
